A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

NCT07456033 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

456

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: Depemokimab
DRUG: Placebo

Sponsor

GlaxoSmithKline